Page last updated: 2024-09-04

vatalanib and tivozanib

vatalanib has been researched along with tivozanib in 3 studies

Compound Research Comparison

Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010)
(vatalanib)
Studies
(tivozanib)
Trials
(tivozanib)
Recent Studies (post-2010) (tivozanib)
276429810523100

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)tivozanib (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.0709
Fibroblast growth factor 2Homo sapiens (human)0.0709
Platelet-derived growth factor receptor betaHomo sapiens (human)0.0709
Platelet-derived growth factor receptor alphaHomo sapiens (human)0.0023
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.0032
Ephrin type-B receptor 2Homo sapiens (human)0.0175
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.0017
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.0783
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)0.07

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, KW; Kim, MS; Kim, Y; Lee, GS; Lee, K; Lee, Y; Song, JY1
Brullo, C; Musumeci, F; Radi, M; Schenone, S1
Aiche, S; Bassermann, F; Becker, W; Canevari, G; Casale, E; Depaolini, SR; Ehrlich, HC; Felder, ER; Feuchtinger, A; Garz, AK; Gohlke, BO; Götze, K; Greif, PA; Hahne, H; Heinzlmeir, S; Helm, D; Huenges, J; Jeremias, I; Kayser, G; Klaeger, S; Koch, H; Koenig, PA; Kramer, K; Kuster, B; Médard, G; Meng, C; Petzoldt, S; Polzer, H; Preissner, R; Qiao, H; Reinecke, M; Reiter, K; Rueckert, L; Ruland, J; Ruprecht, B; Schlegl, J; Schmidt, T; Schneider, S; Schoof, M; Spiekermann, K; Tõnisson, N; Vick, B; Vooder, T; Walch, A; Wilhelm, M; Wu, Z; Zecha, J; Zolg, DP1

Other Studies

3 other study(ies) available for vatalanib and tivozanib

ArticleYear
Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:11

    Topics: Drug Evaluation, Preclinical; Models, Molecular; Protein Kinase Inhibitors; Vascular Endothelial Growth Factor Receptor-2

2010
Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors.
    Journal of medicinal chemistry, 2012, Dec-27, Volume: 55, Issue:24

    Topics: Angiogenesis Inhibitors; Animals; Clinical Trials as Topic; Humans; Models, Molecular; Neoplasms; Pyridines; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Structure-Activity Relationship

2012
The target landscape of clinical kinase drugs.
    Science (New York, N.Y.), 2017, 12-01, Volume: 358, Issue:6367

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Drug Discovery; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Mice; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proteomics; Xenograft Model Antitumor Assays

2017